On April 1 to 4, 2025, the World Health Organization (WHO) Global Programme on Tuberculosis and Lung Health, WHO South East Asia and Western Pacific Regions (SEAR/WPR), together with Unitaid, the Global Fund, KNCV TB Plus and the Vietnam National TB Program hosted the Joint SEAR-WPR workshop to plan the accelerated implementation of new WHO TB policies in Hanoi, Viet Nam.
THE KNOWLEDGE AND TOOLS GAINED DURING THE WORKSHOP HAVE THE POTENTIAL TO DRIVE TANGIBLE PROGRESS IN YOUR RESPECTIVE COUNTRIES.
Tools and Resources
Country experience of programmatic implementation of TPT for contacts of DR-TB patientsExperience of AI-CAD for screening in the Philippines, Cambodia, Nepal and IndiaWHO Policy Updates: TB Infection Testing with TBSTs and IGRAsIndia’s TBSTs & IGRAs ExperienceGroups work: Adjust country TB response/transition plans towards full uptake of the latest WHO guidance in screening and preventionSurvey on potential benefits and challenges of the long-acting injectable medicines for TB treatment (LAIs for TB)Topical issues and forthcoming updates to TB screening recommendations and implementation guidanceSetting the Scene by UnitaidUpdates on WHO guidelines and operational handbook on TPT
TB Diagnostic Section OverviewWHO Policy Updates: Nutritional Interventions and Food Assistance for PwTB and their household contactsWHO Policy Updates: Initial Molecular Testing for TB and Drug-Resistant TBWHO Policy Updates on Targeted Next Generation Sequencing End-to-End Solutions for the Detection of DR-TBPractical implementation considerations for nutritional interventions and food assistance for people with TB and their household contactsNutritional interventions for people with TB and their households BangladeshNutritional Interventions for people with TB and their household in LAO PDR
Recommendations on nutritional assessment & careOverview of WHO Consolidated Guidelines on TB treatment and care 2025 (Part 1)Overview of WHO Consolidated Guidelines on TB treatment and care 2025 (Part 2)Overview of WHO Consolidated Guidelines on TB treatment and care 2025 (Part 3)New modified 9-month regimens for treatment of drug-resistant TB6-month bedaquiline, delamanid, linezolid, levofloxacin and clofazimine (BDLLfxC) regimenManagement of adverse events in MDR/RR-TB treatmentManagement of DR-TB in children and adolescents – implementation considerationsPanel discussion: Support the implementation of the novel DR-TB regimens within a comprehensive quality care packageASCENT DR-TB: Market AccessUNITE4TB: Mid-term progress updatePeerLINC: Scaling Up Capacity Building for New TB RegimensThe use of self-assessment and planning tools to accelerate implementation of new DR-TB treatment policies: Experience from countriesManagement of adverse events in MDR/RR-TB treatmentGlobal Drug Facility’s Products and Services for Accelerated Implementation of New WHO PoliciesCurrent treatment regimens for DR-TB in children and review of recommendation for PNG (Part 1)Current treatment regimens for DR-TB in children and review of recommendation for PNG (Part 2)The Philippines experience on self-assessment and planning
WHO Policy Advances Toward Achieving Universal Access to TB Testing ServicesDevelopment pipeline of novel tests to detect TB (part 1)Development pipeline of novel tests to detect TB (part 2)Development pipeline of novel tests to detect TB (part 3)Global Fund Support for Tuberculosis DiagnosticsCall to action: Close the deadly TB testing gaps in Asia-Pacific
The event took place thanks to the joint efforts of World Health Organization South East Asia/Western Pacific Regions (WHO SEAR/WPR), the National TB Programme in Viet Nam, Unitaid, the Global Fund, and KNCV TB Plus.